Barriers for HIV Cure: The Latent Reservoir
- PMID: 30056745
- PMCID: PMC6152859
- DOI: 10.1089/AID.2018.0118
Barriers for HIV Cure: The Latent Reservoir
Abstract
Thirty-five years after the identification of HIV-1 as the causative agent of AIDS, we are still in search of vaccines and treatments to eradicate this devastating infectious disease. Progress has been made in understanding the molecular pathogenesis of this infection, which has been crucial for the development of the current therapy regimens. However, despite their efficacy at limiting active viral replication, these drugs are unable to purge the latent reservoir: a pool of cells that harbor transcriptionally inactive, but replication-competent HIV-1 proviruses, and that represent the main barrier to eradicate HIV-1 from affected individuals. In this review, we discuss advances in the field that have allowed a better understanding of HIV-1 latency, including the diverse cell types that constitute the latent reservoir, factors influencing latency, tools to study HIV-1 latency, as well as current and prospective therapeutic approaches to target these latently infected cells, so a functional cure for HIV/AIDS can become a reality.
Keywords: HIV; block and lock; latency; persistent infection; shock and kill; viral reservoirs.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
Modeling HIV-1 Latency Using Primary CD4+ T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy.J Virol. 2019 May 15;93(11):e02248-18. doi: 10.1128/JVI.02248-18. Print 2019 Jun 1. J Virol. 2019. PMID: 30918072 Free PMC article.
-
Block-And-Lock Strategies to Cure HIV Infection.Viruses. 2020 Jan 10;12(1):84. doi: 10.3390/v12010084. Viruses. 2020. PMID: 31936859 Free PMC article. Review.
-
HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.Cells. 2021 Feb 23;10(2):475. doi: 10.3390/cells10020475. Cells. 2021. PMID: 33672138 Free PMC article. Review.
-
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.Retrovirology. 2018 Feb 13;15(1):21. doi: 10.1186/s12977-018-0404-7. Retrovirology. 2018. PMID: 29433524 Free PMC article. Review.
-
Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.mBio. 2018 Nov 13;9(6):e02158-18. doi: 10.1128/mBio.02158-18. mBio. 2018. PMID: 30425153 Free PMC article.
Cited by
-
Beyond glycan barriers: non-cognate ligands and protein mimicry approaches to elicit broadly neutralizing antibodies for HIV-1.J Biomed Sci. 2024 Aug 21;31(1):83. doi: 10.1186/s12929-024-01073-y. J Biomed Sci. 2024. PMID: 39169357 Free PMC article. Review.
-
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.Front Immunol. 2019 Apr 9;10:725. doi: 10.3389/fimmu.2019.00725. eCollection 2019. Front Immunol. 2019. PMID: 31024557 Free PMC article. Clinical Trial.
-
Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth.Viruses. 2022 Oct 26;14(11):2350. doi: 10.3390/v14112350. Viruses. 2022. PMID: 36366448 Free PMC article.
-
Immunotherapeutics to Treat HIV in the Central Nervous System.Curr HIV/AIDS Rep. 2020 Oct;17(5):499-506. doi: 10.1007/s11904-020-00519-w. Curr HIV/AIDS Rep. 2020. PMID: 32671567 Free PMC article. Review.
-
Associations between NK Cells in Different Immune Organs and Cellular SIV DNA and RNA in Regional HLADR- CD4+ T Cells in Chronically SIVmac239-Infected, Treatment-Naïve Rhesus Macaques.Viruses. 2022 Nov 13;14(11):2513. doi: 10.3390/v14112513. Viruses. 2022. PMID: 36423122 Free PMC article.
References
-
- Finzi D, Hermankova M, Pierson T, et al. : Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295–1300 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical